Consequently, ACE inhibitors (e.g., Captopril) and angiotensin II type 1 (AT1) receptor blockers (ARBs) (e.g., Losartan) represent, nowadays, important therapeutic strategies against CVD, chronic kidney disease, and type 2 diabetes [16]. The gene discussed is ACE; the disease is chronic kidney disease.